FDA Goes Online For DTC Brief Summary Research
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency’s computer-based direct-to-consumer advertising study will allow FDA to learn how much time consumers spend reading the brief summary.
You may also be interested in...
FDA To Investigate Role Of Context Of Risk Information In DTC Print Ads
Agency will undertake two consumer studies to determine possible options for improving communication of risk information in ads.
FDA To Investigate Role Of Context Of Risk Information In DTC Print Ads
Agency will undertake two consumer studies to determine possible options for improving communication of risk information in ads.
FDA Finalizing Study Protocols For DTC Ad Brief Summary Research
In the first of three studies, FDA will examine consumer responses to a mock weight-loss drug ad to determine how and why consumers use the brief summary. Research data will be collected in the spring, but a final guidance on the brief summary content and format “will be awhile,” FDA says.